BRIEF published on 07/25/2024 at 12:29, 2 years 1 month ago Novacyt Announces Half Year Trading Update for 2024 Revenue Growth Strategic Initiatives Regulatory Approvals Financial Update New Products
PRESS RELEASE published on 07/25/2024 at 12:24, 2 years 1 month ago Half Year Trading Update Novacyt S.A. announces unaudited trading update for H1 2024, showcasing revenue growth, cash position, cost-saving measures, and strategic progress across clinical, instrumentation, and R&D segments Revenue Growth Trading Update Cost-saving Measures Novacyt S.A. R&D Progress
BRIEF published on 07/22/2024 at 12:42, 2 years 1 month ago Results of the Novacyt Annual General Meeting Nomination Resolutions General Assembly Molecular Diagnostics Novacyt
BRIEF published on 07/22/2024 at 12:41, 2 years 1 month ago Novacyt Announces AGM Results and New Board Appointments AGM Executive Directors Molecular Diagnostics Board Appointments Novacyt
PRESS RELEASE published on 07/22/2024 at 12:36, 2 years 1 month ago Result of AGM Novacyt S.A. announces successful AGM with new Executive Directors. Visit the company's website for AGM voting results Voting Results AGM Executive Directors Molecular Diagnostics Novacyt
BRIEF published on 07/18/2024 at 12:40, 2 years 1 month ago Novacyt announces the financial impacts of the agreement with DHSC Treasury VAT Financial Agreement Novacyt DHSC
BRIEF published on 07/18/2024 at 12:38, 2 years 1 month ago Novacyt Announces Financial Impact of DHSC Settlement Financial Impact Novacyt DHSC Settlement VAT Reclaim Clinical Diagnostics
PRESS RELEASE published on 07/18/2024 at 12:33, 2 years 1 month ago AGM Statement on Impact of DHSC Settlement Novacyt provides update on AGM statement regarding DHSC settlement impact, anticipating a potential £7m net cash increase from VAT reclaim. Details of income statement and cash flow implications disclosed Novacyt DHSC Settlement VAT Reclaim AGM Statement Net Cash Increase
BRIEF published on 06/26/2024 at 15:40, 2 years 2 months ago Novacyt Reschedules AGM to 18 July Shareholders AGM Novacyt Online Meeting Rescheduled
PRESS RELEASE published on 06/26/2024 at 15:35, 2 years 2 months ago Notice of rescheduled AGM Novacyt S.A. announces rescheduling of AGM to be held online on 18 July. Shareholders can register to view the meeting via the online platform. Full details to follow. Contact information provided Annual General Meeting Shareholders Novacyt S.A. Online Meeting Rescheduled
Published on 09/16/2026 at 23:45, 4 hours 9 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 6 hours 24 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 10 hours 59 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 12 hours 54 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 13 hours 54 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 23:45, 4 hours 9 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 5 hours 20 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 6 hours 39 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 7 hours 26 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 8 hours 49 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 17:45, 10 hours 9 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 20 hours 54 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 9 hours ago Report on the Combined General Meeting of the 10th of September 2026
